Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.

Background: Percutaneous endoscopic gastrostomy (PEG) is often used to provide nutritional support in locally advanced head and neck cancer patients undergoing multimodality treatment. However, there is little published data on the impact of prophylactic versus reactive PEG. PEG placement may affect swallowing-related physiology, function, and quality of life.

Minimal invasive pocket technique for magnet bone implant hearing aid without fixation.

Introduction: The BAHA (bone-anchored hearing aid) Attract is a magnetic transcutaneous bone conduction device anchored into the temporal bone. The standard surgical technique for BAHA Attract is a multi-tools time-consuming process, which requires a large cutaneous incision. The objective of this study is to describe and test the feasibility of a minimally invasive pocket (MIP) technique for Magnet Bone Implant Hearing Aid (MBIHA) with a modified magnet of BAHA Attract without fixation and without any tissue reduction.

When "AA" is long but "A" is not short: speakers who distinguish short and long vowels in production do not necessarily encode a short-long contrast in their phonological lexicon.

In some languages (such as Dutch), speakers produce duration differences between vowels, but it is unclear whether they also encode short versus long speech sounds into different phonological categories. To examine whether they have abstract representations for 'short' versus 'long' contrasts, we assessed Dutch listeners' perceptual sensitivity to duration in two vowel qualities: [a] and [ɑ], as in the words maan 'moon' and man 'man,' which are realized with long and short duration respectively. If Dutch represents this phonetic durational difference as a 'short'-'long' contrast in its phonology, duration changes in [a] and [ɑ] should elicit similar neural responses [specifically, the mismatch negativity (MMN)].

Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal.

C1 esterase inhibitor (Berinert®) is generally used to treat severe attack of hereditary angioedema. We describe here the case of a patient who presented with a severe angioedema induced by angiotensin-converting enzyme inhibitors (ACEIs) endangering her life. It could be successfully treated with that medicine.